Press Releases

Email Alerts

May 22, 2017

Biostage Announces Receipt of Nasdaq Listing Determination

- Company to request hearing -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 11, 2017

Biostage Reports 2017 First Quarter Financial Results and Provides Business Update

- First quarter marked by operational improvements, clinical readiness and greater scientific validation

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 9, 2017

Dr. Christine Finck of Connecticut Children's Medical Center, Presents Data in Poster Presentation from Collaboration with Biostage at the American Pediatric Surgical Association (APSA) 2017 Annual Meeting

- Dr. Finck's Presentation Awarded Best Poster in Basic Science at APSA

Biostage, Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 5, 2017

Biostage to Host 2017 First Quarter Update Conference Call

- Conference Call with Live Audio Webcast on Thursday, May 11th at 9:00 AM ET -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
May 1, 2017

Biostage to Present at the American Association for Thoracic Surgery Centennial Meeting

- Biostage to present on Monday, May 1 at 3:25 p.m. EDT -

Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...

Show per page